RxDoctor Payments Data

Eric White, OD

Optometrist · San Diego, CANPI 1205808045

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Optos, Inc. at 27.0% of the total. Reporting peaked in 2024 at $2,923 and has fallen 57.9% since, to $1,231 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,204in general payments, 2019–2025

Across 83 payments — averaging $86.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optos, Inc.$2K
  • Coopervision Inc.$2K
  • Carl Zeiss Meditec USA, Inc.$733
  • Johnson & Johnson Surgical Vision, Inc.$568
  • Bausch & Lomb Americas Inc.$375
  • Sight Sciences, Inc.$374
  • plus $2K from 13 others
$306,302in research payments, 2019–2025

Across 109 payments — averaging $2810.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$114K
  • Alcon Research LLC$88K
  • Bausch Health US, LLC$60K
  • Bausch & Lomb Americas Inc.$44K
  • Topcon Healthcare, Inc.$300

What the payments were for

  • Speaking & faculty fees$1,50021%
  • Travel & lodging$1,30618%
  • Food & beverage$3,98555%
  • Entertainment$4136%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,204 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.

See all optometrist providers in California

Medicare billing

Part B allowed, 2024
$11,328
Medicare patients
68
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone22$743

Paid to pharmacies, not to this prescriber.

Other optometrist in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →